NextLeap Ventures
VC Fund
Herzliya, Israel
NextLeap Ventures is an investment firm
- Total investments:
- 19
- Last investment:
- Lead investor:
- 21%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries NextLeap Ventures invests in
Stages NextLeap Ventures invests in
Countries NextLeap Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $450k–$26M
- Series A
- $5.3M–$21M
Investment Focus
Industry
- Software 5 (26%)
- Health Care 5 (26%)
- Big Data 4 (21%)
- Information Technology 4 (21%)
- Biotechnology 3 (16%)
Stage
- Seed 8 (42%)
- Series A 6 (32%)
- Venture - Series Unknown 2 (11%)
- Series B 1 (5%)
- Funding Round 1 (5%)
Country
- Israel 13 (68%)
- United States 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alexa King
Strategic Advisor
|
Strategic Advisor | Total investments: 0 | Find email | |
Oded Agam
Managing Partner & Co-Founder
|
Managing Partner & Co-Founder | Total investments: 0 | Find email | |
Ronny Korner
Managing partner & Co-Founder
|
Managing partner & Co-Founder | Total investments: 0 | Find email | |
Yoav Hochberg
Managing Partner & Co-Founder
|
Managing Partner & Co-Founder | Total investments: 0 | Find email | |
Yosi Govezensky
Managing Partner & Co-Founder
|
Managing Partner & Co-Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Cybord develops technologies that stop counterfeit, defective and malicious electronic components from getting assembled into products during the manufacturing process. Cybord scans each component prior to placement by integrating with electronic product manufacturing equipment, and deep learning algorithms rate each component based on Cybord’sglobal component database. Between 5 to 10% of all electronic components are considered counterfeit, responsible for up to 35% of RMAs. With Cybord, OEMs, EMSs, and distributors ensure their products are of high quality and free of hardware-cyber threats | $8.7M / Series A / Sep 17, 2024 | ||
| Carrar manufactures and designs a wide range of thermal management technology systems for the electric mobility industry. | $5.3M / Series A / Apr 09, 2024 | ||
| CorrActions is a software-based platform that's used in a product with human-machine interaction. | $7.3M / Series A / Dec 12, 2023 | ||
| Cybord develops technologies that stop counterfeit, defective and malicious electronic components from getting assembled into products during the manufacturing process. Cybord scans each component prior to placement by integrating with electronic product manufacturing equipment, and deep learning algorithms rate each component based on Cybord’sglobal component database. Between 5 to 10% of all electronic components are considered counterfeit, responsible for up to 35% of RMAs. With Cybord, OEMs, EMSs, and distributors ensure their products are of high quality and free of hardware-cyber threats | $4M / Seed / Mar 08, 2022 | ||
| Enzymit is creating a new transformation layer for manufacturing by combining computational enzyme design, deep learning, and a proprietary high-throughput discovery platform. We develop novel enzymatic pathways and run them in controllable cell-free production systems. This approach merges the selectivity of biology with the precision ofchemistry, enabling cleaner and more efficient production. Our platform has been validated with pharmaceutical-grade hyaluronic acid (HA), produced at kilogram scale with superior consistency and purity compared to fermentation. We are now advancing toward commercial HA supply while expanding the platform to products like heparin and human milk oligosaccharides (HMOs). | $5M / Seed / Jan 01, 2022 | ||
| ShieldIOT delivers innovative cybersecurity solutions that protect edge devices from security threats and operational risks. Their application-agnostic software solution enables device manufacturers and network operators to automatically secure existing and new devices, across multiple industries, with no need for any development resources orsecurity expertise. | $7.4M / Series A / Nov 19, 2021 | ||
| At NewPhotonics, we specialize in designing innovative Photonics Engines that revolutionize the capabilities of optical communications in data centers, significantly reducing power consumption while improving reliability and eliminating data rate bottlenecks for compute and AI workloads. With a focus on developing Photonic Integrated Circuits(PICs) and optical modules, we continuously push the boundaries of photonics technology. Our unwavering commitment lies in driving innovation within this rapidly evolving field. Join us on our journey as we seek dedicated and highly skilled professionals to contribute to our exciting work | $26M / Seed / Sep 01, 2021 | ||
| TechsoMed is an Israeli based medical device company, developing ultrasound based real-time monitoring systems for thermal ablation procedures. The applications of thermal ablation are numerous: tumor destruction, heart arrhythmia, blood pressure treatments and more. The procedure has market size in the billions, but lacks real-time monitoringcapabilities, causing high failure rates.Their technology offers added value to patients, physicians and insurance companies by solving the high failure rate of these minimally invasive and cost effective procedures. | $7M / Series B / Mar 03, 2021 | ||
| DataLoop's data management and annotation platform streamline the process of preparing visual data for machine and deep learning. Dataloop is used for building and deploying powerful computer vision pipelines – data labeling, automating data ops, customizing production pipelines, and weaving the human-in-the-loop for data validation. Thiseliminates data challenges for companies, allowing them to focus their resources on their core business. The company was founded in 2017 and is based in Herzliya, Tel Aviv. | $11M / Series A / Oct 14, 2020 | ||
| HT BioImaging is a revolutionary patented medical imaging platform technology. Our mission is to detect and classify cancer early on the spot. Our exceptional team includes AI, signal analysis and computer vision experts, heat transfer & thermodynamics top researchers, oncologists, radiologists, and one successful serial entrepreneur. The HTBioImaging system utilizes smart algorithms that are based on signal analysis, computer vision and artificial intelligence to create a new medical imaging modality that will be used in every community clinic and OR. | Venture - Series Unknown / Jul 09, 2020 | ||
| See all 19 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does NextLeap Ventures invest in?
NextLeap Ventures invests primarily in Software, Health Care and Big Data startups, most often at Seed and Series A stage. Most of the 19 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is NextLeap Ventures's check size?
NextLeap Ventures typically joins rounds of $450k–$26M at Seed and $5.3M–$21M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds NextLeap Ventures participates in.
How do I contact NextLeap Ventures?
Public channels for NextLeap Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at NextLeap Ventures?
The team at NextLeap Ventures includes Alexa King (Strategic Advisor), Oded Agam (Managing Partner & Co-Founder) and Ronny Korner (Managing partner & Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
